milwaukee glp-1 medications are changing the conversation around weight loss. In this THRIVE Podcast episode, Dr. Hildebrand of @lakeshorepsychologyservices and Dr. DeGueme break down the science, benefits, and considerations. Listen to the episode Wisconsin BBB scam alert; beware

BPC-157 isnt approved as a drug in any country, and isnt available for compounding

*Our products are manufactured in facilities that follow current Good Manufacturing Practices (cGMP), and we ensure that all product claims, descriptions, and representations are consistent with regulatory standards

Journal of Pharmaceutical and Biomedical Analysis , 192 , 113642 Begines, B., Ortiz, T., Prez-Aranda, M., Martnez, G., Merinero, M., Argelles-Arias, F., & Alcudia, A

Apply an even layer to clean skin

Abstract This large community-based cohort study investigates the impact of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), specifically Liraglutide and Semaglutide, on the risk of developing psychiatric conditions such as depression, anxiety, and suicidal behaviors in patients with obesity